Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Bosch Healthcare Presents Vivalytic Point-of-Care PCR System

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: For the first time, Bosch is organizing a panel discussion with Vivalytic (Photo courtesy of Bosch Healthcare)
Image: For the first time, Bosch is organizing a panel discussion with Vivalytic (Photo courtesy of Bosch Healthcare)

Bosch Healthcare Solutions (Waiblingen, Germany) is present at this year’s MEDICA to showcase new tests and its universal platform for molecular diagnostics at the point of care. The MEDICA is an annual international trade fair for the medical industry. At the trade fair, exhibitors from all over the world present their latest products, services, and technologies in the fields of medicine, health care, and nursing. MEDICA is an important platform for the exchange of knowledge and experience between professionals in the industry, including doctors, nurses, medical technicians, and healthcare managers. In addition to the exhibition, various forums and conferences are held each year, where experts from different areas of the medical industry give presentations and lead discussions. These forums provide a great opportunity for professionals to learn about the latest trends and developments in their respective fields and to exchange ideas with other experts.

This year, for the first time and exclusively, Bosch Healthcare Solutions is organizing a panel discussion with Vivalytic, and to discuss the topic of laboratory diagnostics at the point of care with experts from various industries. Particular importance will be given to point-of-care PCR systems, such as Vivalytic, which provide rapid test results at the point of sample collection and are easy and intuitive to operate. This exclusive event will provide new insights into the "Third Pillar" of diagnostics. The panelists are proven experts in their field and will be sharing some experiential insights on the topic. Visitors can also attend the round table discussion to learn more about the innovative Vivalytic system and the challenges of the diagnostics sector at the point of care.

Related Links:
Bosch Healthcare Solutions

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.